CaroGen
CaroGen is an immunotherapy company that develops vaccine candidates that target hepatitis B and C, as well as other viral agents.
1
Funding Rounds
$150.0k
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Va****** Na**** | - | - | - |
| Bi*** Al******* | - | - | |
| Mi***** Ro*** | - | - | - |
Funding series
Funding Series Analysis
The company CaroGen has raised a total of $150k in funding over 1 rounds.
Key Insights:
- CaroGen seed round: $150k
CaroGen seed round
$150k
Industries
CaroGen is active in the following industries: